AVITA Medical (AVHHL) Net Cash Flow (2019 - 2025)

AVITA Medical has reported Net Cash Flow for 7 years, with the latest figure at -$5.2 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 12.86% year-over-year to -$5.2 million; the trailing twelve-month figure through Dec 2025 stood at -$3.8 million (up 52.81% YoY), and the FY2025 full-year result was -$3.8 million, up 52.81% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$5.2 million, down from $3.2 million in the prior quarter.
• The five-year high for Net Cash Flow was $55.1 million in Q1 2021, with the low at -$64.0 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$7.3 million across 5 years, with a median of -$3.6 million in 2024.
• Annual changes were most pronounced in 2021 — Net Cash Flow jumped 822.38% — and 2025, when it plunged 629.74%.
• AVITA Medical's Net Cash Flow stood at -$50.2 million in 2021, then jumped by 88.66% to -$5.7 million in 2022, then tumbled by 404.57% to -$28.7 million in 2023, then soared by 84.03% to -$4.6 million in 2024, then dropped by 12.86% to -$5.2 million in 2025.
• The last three Net Cash Flow figures came in at -$5.2 million (Q4 2025), $3.2 million (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.